Oncotelic Therapeutics, Inc.
Oncotelic Therapeutics, Inc. (OTLC) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 24 transactions totaling $65.9K, demonstrating a bullish sentiment with $65.9K in net insider flow. The most recent transaction on Jan 22, 2026 involved a transaction of 4,426 shares valued at $0.
OTLC Insider Activity Summary
Who Is Buying OTLC Stock?
No significant insider buying has been recorded for OTLC in the recent period.
Who Is Selling OTLC Stock?
No significant insider selling has been recorded for OTLC in the recent period.
Is Oncotelic Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for OTLC is bullish with an Insider Alignment Score of 100/100 and a net flow of $65.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
OTLC Frequently Asked Questions
Understanding OTLC Insider Activity
Insider trading at Oncotelic Therapeutics, Inc. (OTLC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading OTLC stock, having executed 24 transactions in the past 90 days. The most active insider is Vuong Trieu (Executive), who has made 19 transactions totaling $65.9K.
Related Tools
Track Oncotelic Therapeutics, Inc. Insider Activity
Get notified when executives and directors at OTLC file new Form 4 transactions